ARCHIVES

FDA Approves Lilly’s Alimta For Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

First NCI Director To Resign Due To Presidential Election?

December 15, 2000

NCI Bioinformatics After Kenneth Buetow: Varmus Launches Fundamental Redesign

January 6, 2012

NCI To Offer New Grants In Preventative Oncology -Epidemiology, Biostatistics

October 26, 1979

Program Project Guidelines Available

October 27, 1995

Bristol-Myers, IVAX submit Competing Application for Paclitaxel Use In KS

April 18, 1997

Tacoma Tests Of Two Patients Who Received Bahamas Treatment Are Positive For AIDS; Sera Contaminated

July 12, 1985